IRIS
LO CAPUTO, Sergio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.705
EU - Europa 3.694
AS - Asia 3.205
SA - Sud America 994
AF - Africa 103
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.707
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.587
SG - Singapore 1.538
IE - Irlanda 1.005
RU - Federazione Russa 956
BR - Brasile 835
HK - Hong Kong 515
CN - Cina 483
IT - Italia 325
DE - Germania 303
VN - Vietnam 303
SE - Svezia 295
FR - Francia 259
UA - Ucraina 128
FI - Finlandia 119
GB - Regno Unito 101
AR - Argentina 56
IN - India 50
AT - Austria 49
IQ - Iraq 48
BD - Bangladesh 47
CA - Canada 47
MX - Messico 47
NL - Olanda 39
TR - Turchia 38
ZA - Sudafrica 29
VE - Venezuela 25
ES - Italia 23
JP - Giappone 22
EC - Ecuador 20
PK - Pakistan 19
CZ - Repubblica Ceca 18
UZ - Uzbekistan 18
PL - Polonia 17
BE - Belgio 15
ID - Indonesia 15
CO - Colombia 13
KE - Kenya 13
PH - Filippine 13
PY - Paraguay 13
SA - Arabia Saudita 12
CL - Cile 11
LT - Lituania 11
NP - Nepal 11
PE - Perù 11
AZ - Azerbaigian 10
MA - Marocco 10
TN - Tunisia 10
AE - Emirati Arabi Uniti 9
DZ - Algeria 9
IR - Iran 8
EG - Egitto 7
DO - Repubblica Dominicana 6
ET - Etiopia 6
JO - Giordania 6
BO - Bolivia 5
MY - Malesia 5
NG - Nigeria 5
QA - Qatar 5
KZ - Kazakistan 4
OM - Oman 4
PA - Panama 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
AL - Albania 3
AM - Armenia 3
AU - Australia 3
HU - Ungheria 3
JM - Giamaica 3
KR - Corea 3
RO - Romania 3
BB - Barbados 2
BF - Burkina Faso 2
BH - Bahrain 2
BY - Bielorussia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
GT - Guatemala 2
KH - Cambogia 2
KW - Kuwait 2
LV - Lettonia 2
LY - Libia 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
TL - Timor Orientale 2
TT - Trinidad e Tobago 2
BA - Bosnia-Erzegovina 1
CG - Congo 1
DK - Danimarca 1
EU - Europa 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
IL - Israele 1
IS - Islanda 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
Totale 11.693
Salva come PNG Salva come JPEG
Città #
San Jose 1.174
Dublin 1.004
Singapore 611
Hong Kong 511
Ashburn 401
Santa Clara 235
Nyköping 208
Lauterbourg 196
Dallas 193
Beijing 181
Chandler 165
Munich 162
Moscow 141
Princeton 116
Los Angeles 96
Ho Chi Minh City 95
Helsinki 93
Wilmington 73
New York 65
São Paulo 65
Hanoi 49
The Dalles 42
Frankfurt am Main 39
Nuremberg 39
Dong Ket 34
Des Moines 33
Rio de Janeiro 33
Assago 32
Bari 32
Council Bluffs 28
London 27
Boardman 24
Dearborn 24
Jacksonville 23
San Francisco 22
Tokyo 22
Orem 20
Baghdad 19
Vienna 19
Brasília 18
Brooklyn 18
Shanghai 18
Düsseldorf 17
Johannesburg 17
Nanjing 17
Belo Horizonte 16
Chennai 16
Da Nang 16
Falkenstein 16
Warsaw 16
Boston 15
Stockholm 15
Tashkent 15
Gioia Del Colle 14
Washington 14
Atlanta 13
Brussels 13
Campinas 12
Turku 12
Brno 11
Chicago 11
Curitiba 11
Guangzhou 11
Istanbul 11
Montreal 11
Nairobi 11
Toronto 11
Columbus 10
Norwalk 10
Salvador 10
St Louis 10
Amsterdam 9
Baku 9
Erbil 9
Maceió 9
Milan 9
Porto Alegre 9
Caracas 8
Denver 8
Goiânia 8
Guayaquil 8
Phoenix 8
Wuhan 8
Ankara 7
Canoas 7
Caxias do Sul 7
Foggia 7
Hillsboro 7
Joinville 7
Jyväskylä 7
Mexico City 7
Ninh Bình 7
Ottawa 7
Addis Ababa 6
Ann Arbor 6
Bologna 6
Dhaka 6
Franca 6
Haiphong 6
Lima 6
Totale 6.996
Salva come PNG Salva come JPEG
Nome #
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 197
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus 196
Real Time PCR and Culture-Based Virus Isolation Test in Clinically Recovered Patients: Is the Subject Still Infectious for SARS-CoV2? 118
Peculiar clinical presentation of COVID-19 and predictors of mortality in the elderly: A multicentre retrospective cohort study 118
Tocilizumab and corticosteroids for covid-19 treatment in elderly patients. Journal of Gerontology and Geriatrics 115
Efficacy and Safety of Remdesivir over Two Waves of the Sars-CoV-2 Pandemic 114
Estimating minimum adult HIV prevalence: a cross-sectional study to assess the characteristics of people living with HIV in Italy. 109
2Apolipoprotein B mRNA–Editing Enzyme, Catalytic Polypeptide–Like 3G: A PossibleRole in the Resistance to HIV of HIV-1 Exposed Seronegative Individuals 107
Percorsi di vaccinazione anti-Herpes Zoster nel paziente fragile: proposte dagli specialisti del Policlinico Foggia 99
Monitoraggio virologico in soggetti con infezione da HIV in trattamento con Zidovudina (AZT) 98
Long-term failure of antiviral activity of Zidovudine therapy in anti-HIV positive subjects 97
The Onset of Antinuclear Antibodies (ANAs) as a Potential Risk Factor for Mortality and Morbidity in COVID-19 Patients: A Single-Center Retrospective Study 96
Prevalence of hepatitis virus infections in Albanian refugees. 96
Sex and gender differences in COVID-19: an Italian local register- based study 93
Baricitinib: A chance to treat COVID-19? 89
Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): Data from a real-life setting 85
Two nasal swabs may not be enough to exclude SARS-CoV-2 infection in symptomatic patients 85
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 84
96 Week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: a multicentre Italian experience 83
Anti-nef antibodies and other predictors of disease progression in HIV-1 seropositive injecting drug users 83
A positively selected APOBEC3H haplotype is associated with natural resistance to HIV-1 infection 83
Safety and heart rate changes in Covid-19 patients treated with Remdesivir 83
Association of complement receptor 2 polymorphisms with innate resistance to HIV-1 infection 81
Clinical validation and applicability of different tipranavir/ritonavir genotypic scores in HIV-1 protease inhibitor-experienced patients 81
Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort 79
A 6-amino acid insertion/deletion polymorphism in the mucin domain of TIM-1 confers protections against HIV-1 infection 79
Identification of a Specific miRNA Profile in HIV-Exposed Seronegative Individuals 78
. Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort. 78
A comprehensive development agenda on tenofovir alafenamide in clinical practice 78
Monkeypox virus infection mimicking primary syphilis 77
Influence of Gender, Age, and Transmission Category on the Progression From HIV Seroconversion to AIDS 77
Interleukin 21 (IL-21)/microRNA-29 (miR-29) axis is associated with natural resistance to HIV-1 infection 77
Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment 76
Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress? 76
A common polymorphism in TLR3 confers natural resistance to HIV-1 infection 75
Comparison between Rules-Based Human Immunodeficiency Virus Type 1 Genotype Interpretations and Real or Virtual Phenotype: Concordance Analysis and Correlation with Clinical Outcome in Heavily Treated Patients 75
Efficacy and Safety of Remdesivir over Two Waves of the SARS-CoV-2 Pandemic 74
Pregnancy Outcomes Among ART-Naive and ART-Experienced HIV-Positive Women: Data From the ICONA Foundation Study Group, Years 1997–2013 74
Resistance to Dideoxynucleoside Reverse Transcriptase Inhibitors: Genotypic-Phenotypic Correlations 74
Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein rev 73
Lost to follow-up: a challenge over 10 years 73
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 72
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 72
HIV susceptibility to amprenavir: phenotype-based versus rules-based interpretations 71
IL-22 Participates in an Innate Anti-HIV-1 Host-Resistance Network through Acute-Phase Protein Induction 71
Twenty Years Later: the Recent Trends of HIV-infection – Evidence from an Italian Region 70
A Randomized Controlled Trial to Evaluate Antiretroviral Salvage Therapy Guided by Rules-Based or Phenotype-Driven HIV-1 Genotypic Drug-Resistance Interpretation With or Without Concentration-Controlled Intervention: The Resistance and Dosage Adapted Regimens (RADAR) Study 69
An intricate case of multidrug resistant Plasmodium falciparum isolate imported from Cambodia. 69
A role for mucosal immunity in resistance to HIV infection 69
. Reduced community viral load does not coincide with a reduction in the rate of new HIV diagnoses and recent infections: data from a region of southern Italy 68
Low Prevalence of Antibodies to SARS-CoV-2 and Undetectable Viral Load in Seropositive Blood Donors from South-Eastern Italy 68
HIV rapid test in a community setting as a strategy to improve access to HIV testing: Data from a multicentre experience in Italy 68
Cytomegalovirus Coinfection Is Associated With an Increased Risk of Severe Non-AIDS-Defining Events in a Large Cohort of HIV-Infected Patients 67
Self-Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV Infection 67
Letter to the editor: switching treatment to lamivudine plus boosted atazanavir or darunavir in virologically suppressed HIV-infected patients - evidence from a large observational cohort 67
Decrease in Incidence Rate of Hospitalizations Due to AIDS-Defining Conditions but Not to Non-AIDS Conditions in PLWHIV on cART in 2008-2018 in Italy 66
Prevalence and genetic diversity of Blastocystis sp. among autochthonous and immigrant patients in Italy 66
Assessing ChatGPT's Potential in HIV Prevention Communication: A Comprehensive Evaluation of Accuracy, Completeness, and Inclusivity 65
Evaluation of the effect of protective genetic variants on cart success in hiv-1-infected patients 65
Marked decrease in acquired resistance to antiretrovirals in latest years in Italy 65
HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients 65
Peculiar clinical presentation of COVID-19 and predictors of mortality in the elderly: A multicentre retrospective cohort study 64
Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy 64
Durability and tolerability of first-line regimens including two nucleoside reverse transcriptase inhibitors and raltegravir or ritonavir boosted-atazanavir or -darunavir: data from the ICONA Cohort 64
Safety and efficacy of daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohorts 64
Virological response and retention in care according to time of starting ART in Italy: data from the Icona Foundation Study cohort 63
Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure 62
Severity of covid‐19 patients predicted by serum sphingolipids signature 62
Neuropsychiatric Disorders in Pediatric Long COVID-19: A Case Series 61
An evolutionary analysis of antigen processing and presentation across different timescales reveals pervasive selection. 61
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 61
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 61
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 60
Correlation between seroreactivity to HIV-1 V3 loop peptides and male-to-female heterosexual transmission 60
Difficulties in classifying a/g recombinants: methodological problems or genetic variability? 60
Doravirine Plus Integrase Strand Transfer Inhibitors as a 2-Drug Treatment–Switch Strategy in People Living with HIV: The Real-Life DORINI Multicentric Cohort Study 59
Prevalence and genetic diversity of Blastocystis sp. among autochthonous and immigrant patients in Italy 59
Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study 59
Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: Prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patients 59
Distinct patterns of HIV-specific memory T lymphocytes in HIV-exposed uninfected individuals and in HIV-infected patients 59
RADAR Study Group of MASTER Cohort “Influence of viral chronic hepatitis co-infection on plasma drug concentrations and liver transaminase elevations upon therapy switch in HIV-positive patients 59
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 59
Knowledge, attitudes, and practices about HIV and other sexually transmitted infections among High School students in Southern Italy: A cross-sectional survey 58
Long-Term Effectiveness of Rilpivirine-Based Single-Tablet Regimens in a Seven-Year, Two-Center Observational Cohort of People Living with HIV 58
Successful Treatment of Aortic Endocarditis by Achromobacter xylosoxidans with Cefiderocol Combination Therapy in a Non-Hodgkin Lymphoma Patient: Case Report and Literature Review 57
Toll-like receptor activation pathways in HIV-1 exposed seronegative individuals 57
Influence of Genotype 3 Hepatitis C Coinfection on Liver Enzyme Elevation in HIV-1-Positive Patients After Commencement of a New Highly Active Antiretroviral Regimen: Results From the EPOKA-MASTER Cohort 57
Genotypes at chromosome 22q12-13 are associated with HIV-1-exposed but uninfected status in Italians 57
Italian Consensus Statement on Management of HIV-Infected Individuals with Advanced Disease Naïve to Antiretroviral Therapy 57
Apulian infectious diseases network: survey on the prevalence of delta infection among chronic HBV carriers in Apulia 56
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 56
Impact of vaccination on electrocardiograms of hospitalized patients for Covid-19 55
Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registry 55
Clinical Characteristics, Outcomes, and Risk Factors of Patients Hospitalized for COVID-19 across the Latest Pandemic Waves: Has Something Changed? 55
Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians’ and nurses’ points of view 55
The mucosae-associated epithelial chemokine (MEC/CCL28) modulates immunity in HIV infection 55
Durability of Second Antiretroviral Regimens in the Italian Cohort Naive Antiretrovirals Foundation Study and Factors Associated with Discontinuation 55
Risk of Developing Specific AIDS”Defining Illnesses in Patients Coinfected with HIV and Hepatitis C Virus With or Without Liver Cirrhosis 55
Characterization of viro-immunological responses in a closely followed cohort of heavily pretreated patients: evidence from the GenPheRex Study 55
Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort) 55
Totale 7.431
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.994
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.994
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021179 0 0 0 0 0 0 0 0 0 91 11 77
2021/2022492 81 3 3 15 30 26 12 50 63 36 24 149
2022/20231.805 164 27 90 36 35 117 12 62 1.116 94 28 24
2023/2024558 68 34 28 16 30 96 65 12 108 21 9 71
2024/20253.546 196 64 69 66 64 390 669 218 1.013 188 252 357
2025/20265.434 334 430 670 872 280 241 1.365 624 346 272 0 0
Totale 12.432